A role for interleukin-21 (IL-21) has recently been found in several diseases, but contribution to mucosal defences has not been described. In BALB/c mice infected with respiratory syncytial virus (RSV), IL-21 depletion had little effect in primary infection. However, depletion of mice during priming with recombinant vaccinia expressing RSV G protein (which primes RSV-specific T helper type 2 cells and causes lung eosinophilia during RSV infection) further exacerbated pathology during RSV challenge, with reduced viral clearance and impaired virus-specific serum antibody responses. This enhancement was accompanied by lymphocyte, neutrophil, and antigen-presenting cell recruitment to the lungs, with increased bronchoalveolar lavage interferon-c and IL-17 levels. Adoptive transfer of splenic CD4 Tcells from depleted mice into naive recipients replicated these effects, indicating that IL-21 mediates its effects via CD4 T cells. Endogenous IL-21, therefore, has potent and specific effects on mucosal antiviral responses, assisting viral clearance, regulating pulmonary T-and B-cell responses, and inhibiting IL-17 production.
INTRODUCTION
Respiratory syncytial virus (RSV) is a major cause of viral bronchiolitis in infants, 1 also causing seasonal exacerbations and deaths due to respiratory disease in elderly persons. 2 The immune response to RSV infection is complex, involving innate, humoral, and cellular immune responses; all have a role in both antiviral protection and disease pathogenesis. 3 RSV vaccine development has been hampered by the failure of a formalin-inactivated RSV vaccine in the 1960s, which led to disease exacerbation after subsequent natural viral infection associated with excessive lung inflammation. Several hypotheses have been advanced to explain disease exacerbation, including vaccine-triggered T helper type 2 (Th2)-biased CD4 T-cell responses caused by carbonylation 4 and low-avidity poorly neutralizing antibodies that form immune complexes in the lungs. 5 In addition, IL-17 production by CD4 T cells has recently been implicated in enhanced disease. 6, 7 Interleukin (IL)-21 is a regulatory cytokine produced by activated CD4 T cells 8 natural killer (NK) T cells, 9 T follicular helper cells 10 and Th17 cells. 11 Although IL-21 production is restricted to a few cell types, its receptor (IL-21R), is expressed on CD4 and CD8 T cells, B cells, NK cells, NK T cells, gd T cells, dendritic cells (DCs), macrophages, keratinocytes, and fibroblasts. 12, 13 IL-21 has been reported to control the differentiation and functional activity of T cells, 8 B cells, 14 and NK cells, 15 to limit the differentiation of regulatory T cells, 16 and promote T cells resistance to regulatory-T-cell-mediated immune suppression. 17 It also stimulates epithelial cells and fibroblasts to produce inflammatory mediators. 13, 18 Our understanding of the role of IL-21 in T-cell differentiation is evolving rapidly. The differentiation of naive T cells into Th2 cells may be enhanced by IL-21, 19 while under other conditions it may drive T cells and NK cells towards interferon (IFN)-g production 20 and promote Th17 differentiation. 21, 22 IL-21, like IL-10, is produced by all pro-inflammatory T-cell lineages, indicating that it may have crucial anti-inflammatory functions by regulating T-cell activation. For example, IL-21 has been shown to inhibit immediate hypersensitivity reactions 1 in the skin, 23 and CD8 T-cell responses to tumors. 24 It boosts IL-10 production in visceral leishmaniasis 25 by human naive CD4 T cells, 26 Tr1 cells, 27 and NK cells. 28 A lack of IL-21 may lead to dysregulated responses against hepatitis B virus in the young 29 and boost IL-17 production by CD4 T cells in Listeria monocytogenes infection. 30 Increased IL-21 expression by CD4 T cells was associated with control of HIV replication, but this may simply reflect greater T-cell activity. 31, 32 Its increased production has also been positively correlated in several diseases, but this again may reflect self-regulation by activated T cells. 33, 34 Although the role of IL-21 has been studied in many diseases, there is little known about its role in respiratory infections. In this study, we have used a well-characterized mouse model of immunization-enhanced RSV bronchiolitis to investigate the role of IL-21 on CD4 T-cell responses to RSV infection. We found that IL-21 depletion at immunization compromised viral clearance, significantly inhibited production of virus-specific serum antibody levels, and caused pronounced dysregulation of the CD4 T-cell response.
RESULTS

IL-21 depletion increases CD4 T-cell responses to primary RSV challenge
We determined the effect of IL-21 depletion on responses to primary RSV infection in naive mice. Disease (measured by weight loss) is negligible until d5-7 post challenge (PC) and peaks at d6-7 PC. Although weight loss increased with IL-21 depletion, the change was not significant (Figure 1a) . In primary infection, RSV replication is detectable at d2 PC, peaks at d4 PC, and returns to baseline by d7 PC. IL-21 depletion did not alter this kinetic, but there was a significant decrease in L gene expression levels in depleted mice on d4 PC ( Figure 1b) .
Next, we measured T-cell and NK cell recruitment into the airways. CD8 T-cell and NK cell recruitment or activation were unaffected by depletion, but there was a significant increase in CD4 T-cell recruitment at d7 PC (Figure 1c) , especially of ICOS (inducible costimulatory molecule)-expressing CD4 cells (Figure 1d ). We then tested the effect of IL-21 depletion on bronchoalveolar lavage (BAL) cytokines and chemokines, markers of immune activation in the lung. We could not detect IL-21 (data not shown), and IL-4 and tumor necrosis factor levels were not affected by IL-21 depletion. By contrast, the proinflammatory mediators IFN-g and RANTES (regulated and normal T cell expressed and secreted) both increased in depleted mice (Figure 1e ). We observed a threefold increase in the proportion of CD4 T cells producing IFN-g in IL-21-depleted mice (Figure 1f) . Thus, endogenous IL-21 tends to restrain inflammation and antiviral defense, but the effects are mild in primary RSV infection and are mediated primarily via CD4 T cells.
IL-21 depletion during priming exacerbates immunopathology after RSV challenge
In order to enhance the dependency of inflammation on the CD4 T-cell response and to explore the effects of IL-21 in more detail, we opted to study the effects of IL-21 on RSV disease augmented by previous senitization via cutaneous immunization with recombinant vaccinia virus expressing RSV surface glycoprotein G (rVV-G). This prime-challenge regimen induces a strong CD4 T-cell-mediated, Th2-driven immunopathology that causes lung eosinophilia after RSV challenge 35 and parallels some of the clinical and immunological features observed in infantile RSV bronchiolitis. Depletion had no effect on vaccinia lesions or on resolution of cutaneous infection (data not depicted), and our analysis, therefore, focussed on the effects of IL-21 depletion on the pulmonary response to RSV challenge.
rVV-G sensitized mice lost weight immediately after RSV challenge, peaking at B15% on d4 PC, with recovery by d7 PC (Figure 2a) . IL-21 depletion significantly increased the magnitude of weight loss, peaking at B25% on d5-6 PC. Moreover, the kinetic of recovery was delayed with no mouse recovering fully by d8 PC. In some experiments, weight loss was followed to d14 PC but still showed incomplete recovery (data not depicted).
Weight loss correlates with recruitment of activated cells to the lung and airway; therefore, we studied cell recruitment by flow cytometry, observing that both total BAL and lung cell counts were significantly increased in IL-21-depleted mice on d5 PC. Specifically, we observed significant increases in recruitment of CD4 T cells, CD8 T cells, and NK cells to the BAL (Figure 2c ). Activity of recruited T cells (as measured by ICOS and CD69 expression) was also greater in depleted mice (data not shown). By contrast, we observed a significant reduction in B cells in IL-21-depleted mice (Figure 2c ). IL-21 depletion also boosted granulocytosis: we observed a significant increase in neutrophil (CD3 Figure 2d ). Recruitment of DCs was also observed to increase in depleted mice using three separate markers: MHCII (major histocompatibility complex II), CD11b, and CD11c ( Figure 2e ). Similar changes were also observed in recruitment to the lung tissue (data not shown). We also measured IFN-g, IL-4, IL-10, and IL-17 levels in the BAL fluid of mice on d5 PC and found that there were significant increases in IFN-g, IL-10, and IL-17, and a significant decrease in IL-4, in IL-21-depleted mice (Figure 2f ). IL-21 was barely detectable (o35 pg ml À 1 ) in BAL fluid (data not shown).
Next we checked whether viral clearance was affected. Mice primed with rVV-bgal, which develop no anti-RSV memory, exhibited significant viral replication at d4 PC. Immunization reduced viral replication to undetectable levels; however, viral genome was detectable in IL-21-depleted mice, suggesting clearance had been compromised (Figure 2b) . IL-21 depletion did not alter the kinetics of replication, and by d7 PC, all mice had cleared the virus.
IL-21 depletion reduces antibody production in primed, RSV-challenged mice As viral-specific antibody is a crucial component of long-term protective anti-viral immunity, we determined the effect of IL-21 depletion on serum RSV-specific antibody levels. Priming with RSV G protein results in weak but detectable ARTICLES MucosalImmunology | VOLUME 6 NUMBER 4 | JULY 2013 levels of RSV-specific immunoglobulin G1 (IgG1) and IgG2a ( Figure 3a) . No virus-specific IgA or IgE was detected (data not shown). IL-21 depletion reduced RSV-specific IgG1 levels but not IgG2a (Figure 3a) . We then measured serum RSV-specific antibody 14 d post RSV challenge when the virus has been cleared and cellular response reduced to baseline levels. There were enhanced RSV-specific IgG1 and IgG2a levels in control mice compared with pre-RSV challenge, and IL-21 depletion significantly reduced levels of both antibody isotypes (Figure 3b ).
IL-21 depletion at priming boosts the number of activated lung CD4 T cells after RSV challenge
To examine how IL-21 depletion affects CD4 T-cell differentiation, we determined FoxP3, RORgt (related orphan receptor-gt), and T-bet expression in splenic CD4 T cells before RSV challenge and lung CD4 T cells at d5 PC (peak of disease severity). IL-21 depletion did not alter FoxP3 (Figure 4a As IL-21 depletion increased total numbers of RORgt þ and T-bet þ CD4 T cells in BAL and lung, we wanted to confirm that lung CD4 T cells were producing increased levels of IL-17 and IFN-g. Therefore, 5 d PC, we stimulated lung cells with either media or aCD3/28 beads overnight and stained them for cytokine production the next day. There were increased percentages of CD4 T cells in IL-21-depleted mice ( Figure 6a ). Approximately 12% of these cells from both the groups of mice produced IFN-g (but no IL-17) after stimulation with media alone (Figure 6b ). Production of both IFN-g and IL-17 increased when the cells were stimulated with aCD3/28 beads o/n ( Figure 6c) . However, lung CD4 T cells from IL-21-depleted mice produced significantly more IFN-g and IL-17 (both single and co-producing populations) than control cells (Figure 6d ). We also determined whether there was increased production post priming in the spleen (see Supplementary Figure S3 online). There was no change in IFN-g production; however, there was a small but significant increase in IL-17 production in the depleted group (see Supplementary Figure S3c ,d online).
IL-21 depletion enhances cytokine production by lung CD4 T cells
To determine the effect of IL-21 depletion on cytokine production by antigen-specific CD4 T cells, we sorted CD4 T cells and DCs from the lungs of rVV-G primed, control, and IL-21-depleted mice at the peak of disease (d5 PC) after RSV challenge. The DCs were pulsed with specific G peptide (p31; G184-198) or control peptide (p11; G64-78) and co-cultured with CD4 T cells. Cytokine levels in the supernatant were þ , and ICOS þ ) when CD4 T cells were administered from IL-21-depleted mice. CD4 T cells from IL-21-depleted mice also recruited more BAL-recipient NK cells, though their activity (as measured by CD69 expression) was identical ( Figure 10f ). This increase in T-bet þ CD4 T cells, CD8 T cells, and NK cells increased BAL IFN-g (Figure 10g ) but not IL-4 levels ( Figure 10h ). By contrast, there was no increase in BAL IFN-g and a significant increase in IL-4 when control CD4 T cells were administered. BAL IL-17 levels were unaltered (Figure 10i) .
To confirm whether these effects of IL-21 depletion were restricted to CD4 T cells, we performed parallel experiments in mice primed with RSV M2 protein (rVV-M2). Priming with this protein elicits a CD8 T-cell memory that is recalled to the pulmonary compartment upon RSV challenge. IL-21 depletion had less significant effects on disease severity and no significant effect on CD8 T-cell influx into the airway or lung tissue. Moreover, there were no significant changes in immune responses between mice receiving CD8 T cells from control or IL-21-depleted mice, confirming that the observed effects described in this study are limited to CD4 T cells (data not shown).
DISCUSSION
Using IL-21 depletion, we found that endogenous IL-21 skews CD4 T-cell activity: it inhibits recruitment of RORgt þ and T-bet þ CD4 T cells during RSV challenge and reduces IFN-g and IL-17 production. Depletion also enhanced recruitment of CD8 T cells, NK cells, and neutrophils during subsequent RSV infection, indicating an enhanced inflammation with delayed recovery. Many of these features could be transferred into naive recipients by injection of splenic CD4 T cells from IL-21-depleted mice, indicating direct involvement of T cells programmed in the presence of IL-21 in these responses.
Although primarily anti-inflammatory, endogenous IL-21 seemed to promote clearance of RSV in vivo and enhance virus-specific serum antibody production, suggesting that IL-21 has therapeutic potential in boosting protective immunity to viral infection, while inhibiting pathological responses.
Studies of the effects of IL-21 on CD4 T-cell differentiation suggest that it has diverse actions on Th1, Th2, and Th17 lineage development. 19, 20, 22 As we observed no change in FoxP3, RORgt, or T-bet expression in splenic CD4 T cells post priming with IL-21 depletion, we infer that endogenous IL-21 does not alter CD4 T-cell differentiation under these conditions. However, we cannot rule an effect on antigen-specific CD4 T cells, as we did observe a small but significant increase in IL-17 (but not IFN-g) protein upon specific CD4 T-cell stimulation in vitro (see Supplementary Figure S3 
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T-bet RORγt RORγt T-bet Figure 4 Interleukin-21 (IL-21) depletion has no effect on FoxP3, RORgt (related orphan receptor-gt), and T-bet expression by splenic CD4 T cells after priming with recombinant vaccinia virus. Mice were immunized as described in Figure 2 . Fourteen days post priming, spleens were harvested. CD4 T cells were stained for (a) FoxP3, (b) RORgt, or (c) T-bet according to the manufacturer's instructions. The percentage of CD4 T cells expressing each transcription factor was determined by flow cytometry and is shown in each dotplot. Grouped data for (d) percentage and (e) total number are also shown. The graph is representative of two independent experiments of five mice per group. Con, control; Dep, depleted.
disease severity. As this change was not evident in splenic CD4 T cells (Figure 4a) , we conclude that the effects are local and specific. Therefore, IL-21 not only limits CD4 T-cell differentiation into pro-inflammatory lineages, but also aids in the development of regulatory T-cell populations to reduce pathological responses. The consequences of the increased pro-inflammatory potential (and reduced regulatory activity) of these CD4 T cells are evident after RSV challenge. Weight loss is a reliable marker of pathology in this model, and the magnitude and kinetic of weight loss in depleted mice is greater and more prolonged than controls. The magnitude of weight loss positively correlates with the degree of cellular recruitment into the pulmonary compartment. In this study, increases in CD4 T cells and neutrophils were greatest, followed by CD8 T cells and NK cells, and finally DCs. As priming activates CD4 T cells, it is not surprising that (upon recall) their numbers would increase greatly in the event of increased activation and expansion caused by a lack of immunoregulatory IL-21. By contrast, the threefold increase in neutrophilia likely reflects an increase in chemokine levels (e.g., CXCL1) caused by a more pro-inflammatory environment. A similar mechanism may be responsible for the increase in NK cell numbers. CD8 T cells respond to RSV challenge in an antigen-specific manner, but it is likely that increased chemokine levels and increased number of CD4 T cells also help contribute to their increased recruitment. Nevertheless, an effect of increased DC activation and recruitment cannot be ruled out as their recruitment increased threefold in the airway at the peak of pathology, Thus, it is likely that increased DC recruitment to the airway will result in increased T-cell activity and cytokine production. IL-21 reduces MHCII expression on DC, thereby reducing their ability to activate CD4 T cells. 36 This is supported by DC/CD4 T-cell co-culture, demonstrating that CD4 T cells from depleted mice produced more cytokine than control cells. The increase in cytokine production in a subset-independent manner further suggests that IL-21 is an anti-inflammatory cytokine and not subset-biasing. Despite this, no increase of IL-4 was observed in the airway of depleted mice. This indicates that CD4 T-cell activation alone does not determine the IL-4 level in the airway, and that other factors in the environment also contribute. This may include IFN-g-producing NK cells and CD8 T cells that would reduce IL-4 and Th2 cytokine secretion, as was observed in the adoptive transfer experiments. B cells may also be an IL-4 source, 37 and their reduction both in this study and in previous RSV disease studies with strong Th1 cytokine profiles also indicates them as a source. 38 Our data indicate an increase in Th1/Th17 pathological responses in depleted mice. The increase in IL-10 may reflect self-regulation by activated T cells, the importance of which has been highlighted in RSV disease recently. 39 The increase in IL-10 was not associated with increased FoxP3 cell numbers, which was actually reduced at this time. The increase in lung CD4 T cells from depleted mice expressing T-bet, RORgt, and producing IFN-g and IL-17 correlates with the increased pathology, and cells making these mediators may be pathogenic in RSV disease. 7 Indeed, CD4 T-cell transfer into naive recipient mice failed to protect against pathology upon viral challenge. This failure was associated with increased CD4 T-cell recruitment and increased IFN-g production, similar to the phenotype observed during primary infection and in the recall response of primed mice.
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Viral clearance is associated with strong cellular immune responses; however, in this study, we observed a compromised anti-viral response. This is likely due to the reduction in antiviral serum antibody levels, indicative of reduced B-cell activity. The reduced B-cell recruitment to the airway supports this. The reduction in viral replication during primary RSV infection and adoptive transfers is likely due to enhanced lymphocytosis as no virus-specific antibody is present at this time. Several studies have demonstrated a crucial role for IL-21 on both B-cell activation 40 and cells crucial for their activation (e.g., follicular T helper (Tfh) cells 10, 41 ). Early studies demonstrated that IL-21 was crucial for development of antibody-secreting plasma cells 42 and suggest a crucial role for Tfh-derived IL-21 in antibody production. 43 More recent studies show that IL-21 enhances Bcl-6-mediated Tfh-cell development 41, 44 and has a critical role in germinal center formation. 45, 46 Our present studies show that IL-21 is crucial for optimal antibody production and that its depletion is detrimental to shortand long-term protection against viral challenge.
Our studies contrast with a recent report of studies of pneumovirus of mice (PVM). 47 Although PVM and RSV are similar virologically, PVM induces much more severe disease. The studies of PVM show that IL-21RKO mice exhibit reduced disease, cell recruitment, and chemokine/cytokine production; moreover, mice that constitutively overexpress IL-21 suffer enhanced disease, with increased recruitment and boosted chemokine/cytokine production. These studies were in C57Bl/6 mice rather than BALB/c, and genetic background is known to be important in many immunological responses. In addition, the effects of transient mediator depletion during priming are likely to differ from the effects of life-long genetic deletion, in which compensatory mechanisms occur.
In conclusion, our findings show that IL-21 has a key role in limiting the magnitude and regulating the phenotype of virusspecific CD4 T-and B-cell responses and in anti-viral immunity in RSV disease. These new insights extend our understanding of the role of IL-21, which has not previously been shown to be involved in defense against respiratory infection. Together with previous studies, our findings highlight the inherent complexity of IL-21's functions in respiratory disease. Moreover, given the genetic heterogeneity of the human population, further research is warranted to fully understand the immune function of IL-21 in the respiratory tract. Based on our findings, we speculate that IL-21 has therapeutic potential, and co-administration with vaccine antigens might be particularly effective at inducing protective immune responses in infancy, when IL-21 responses are impaired. 29 
METHODS
Virus and mice. HEp-2-cell-grown plaque-purified A2 strain of RSV was snap frozen and assayed for infectivity. 38 rVV-G (a kind gift of Gail Wertz, USA) was stored at À 801C. All virus preparations were free of mycoplasma (Gen-Probe, San Diego, CA).
Eight-week-old female BALB/c mice were purchased from Harlan Olac (Bicester, UK) and kept in specific pathogen-free conditions. All protocols used in this study were reviewed and approved by ethics, safety, and regulatory committees.
Mouse infection and treatment. For skin infection, rumps were shaved, decornified, and infected with rVV-G (10 ml, 10 6 pfu). 38 Some mice were treated (IP) with 0.5 mg anti-IL-21 polyclonal (a kind gift of Kresten Skak from Novo Nordisk, Denmark) or isotype control antibody in 0.5 ml phosphate-buffered saline (PBS), 1 d before and 2 d after immunization. For challenge, mice were anesthetized and infected intranasally with 100 ml (5 Â 10 5 pfu) of RSV. Mice were weighed daily thereafter.
The in vivo neutralizing activity of the anti-IL-21 polyclonal antibody was confirmed before use. First, we measured total serum IgG by ELISA in mice treated on d0, 2, 4, and 6 with vehicle or rmIL-21 (10 ng per dose; intranasally). rmIL-21 significantly increased total serum IgG levels, and this was ablated by treatment on d( À 1) and d( þ 2) with anti-IL-21 antibody (0.5 mg; IP) but not control antibody (see Supplementary Figure S5a online) .
We also determined the time after administration that anti-IL-21 antibody remained effective. rmIL-21 was administered as previously described, anti-IL-21 (or control) antibody given on d0 (0.5 mg; IP), and total serum antibody levels were determined on d0, 3, and 6. We found that anti-IL-21 antibody reduced rmIL-21-mediated increases in total serum IgG on d3, but by d6 antibody levels had returned to d0 levels (see Supplementary Figure S5b online). This confirmed that the anti-IL-21 antibody was effective for up to 6 d in vivo.
Cell recovery. After killing by IP injection of 3 mg of pentobarbital, BAL fluid, lung tissue, spleen, and serum were harvested. 38 In brief, the lungs were inflated twice with 1 ml of 12 mM lidocaine in Earle's Balanced Salt Solution and kept on ice. The BAL fluid was centrifuged, the supernatant removed, and stored at À 801C. Pelleted cells were resuspended in RPMI with 10% fetal calf serum, 2 mM ml À 1 glutamine, 50 U ml À 1 penicillin, and 50 mg ml À 1 streptomycin (''R10F''). The cell suspension was passed through a 100-mm filter (Sartorius, Epsom, UK) and red blood cells lysed with ACK (ammonium chloridepotassium) buffer. The cells were washed, resuspended in R10F, and live cells counted using trypan blue.
Quantification of viral replication and gene expression. Total RNA was extracted and stored in cell lysis and RNA stabilisation RLT buffer (Qiagen, Crawley, UK). In all, 1 mg total RNA was used to synthesize cDNA using random hexanucleotides in 20 ml. Viral L gene copies were measured against standard plasmids (10 7 -10 1 copies) and a non-template controls. Also, 100 ng cDNA was used per reaction with forward primer 
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Depleted CD4 Naive CD4 Figure 9 Interleukin-21 (IL-21) depletion at priming significantly alters the number FoxP3 þ , RORgt þ (related orphan receptor-gt þ ), and T-bet þ CD4 T cells 28 days post respiratory syncytial virus challenge. Mice were treated as in Figure 2 . Twenty-eight days post challenge, spleen cells from both the groups plus naive mice were harvested and processed. CD4 T cells were stained for (a) FoxP3, (b) RORgt, or (c) T-bet according to the manufacturer's instructions. The percentage of CD4 T cells expressing each transcription factor was determined by flow cytometry and is shown in each dotplot. Grouped data for (d) percentage and (e) total number are also shown. The graph is representative of two independent experiments of five mice per group. Student's t-test result; **Po0.01, ***Po0.001.
Staining and flow cytometric analysis of surface and intracellular antigens. Cellular phenotyping was performed on BAL, lung, and spleen cells by flow cytometry as described. 38 Briefly, cells were transferred into 96-well, v-bottomed plates and washed in FACS (fluorescent-activated cell sorter) staining buffer (PBS/bovine serum albumin (1% w/v)/NaN 3 (0.1% w/v)). F c g receptors were blocked using aCD16/32 antibodies, and cells were stained using antibodies against multiple cell markers. All antibodies were purchased from Biolegend (London, UK) unless otherwise stated and used at pre-optimized concentrations. After staining (except for transcription factor expression, see below), cells were washed in PBS and fixed using paraformaldehyde (4% v/v) for 20 min. Cells were washed and resuspended in FACS staining buffer and taken for analysis. At least 40 Â 10 3 cells from each sample were collected on a Dako Cyan flow cytometer (Ely, UK). Analysis was performed using Winlist6.0 (Verity, Topsham, ME).
For transcription factor expression, cells were washed in PBS and fixed and permeabilized using a solution containing paraformaldehyde/saponin (eBioscience, Hatfield, UK) overnight at 4 1C. Cells were then washed in permeablisation buffer (eBioscience) and incubated in the same buffer (50 ml per well) for 15 min. Cells were then stained for FoxP3, RORgt, or T-bet (1:200 dilution; eBioscience) by adding permeablisation buffer (50 ml per well) containing relevant antibodies and incubated for 45 min at 4 1C. Cells were washed in permeabilisation buffer and closed by washing with FACS buffer. Cells were resuspended in FACS staining buffer and taken for analysis. At least 100 Â 10 3 cells from each sample were collected on a Dako Cyan flow cytometer. Analysis was performed using Winlist6.0 (Verity).
In vitro cytokine production by lung or spleen CD4 T cells. Lungs were harvested and processed as described above. Cells were counted using trypan blue exclusion assay, set up in 48-well plates (2 Â 10 6 per well), and stimulated with media, RSV (multiplicity of infection 2.0), or aCD3/aCD28-coated beads (Invitrogen, Paisley, UK; pre-titrated to 10 ml stock per 10 6 cells) at 37 1C/5% CO 2 overnight. Next day, supernatants were harvested and stored at À 80 1C before analysis of cytokine levels by ELISA. The cells were washed in FACS staining buffer, and capture reagents for IFN-g, IL-4, IL-10, and IL-17 (Miltenyi Biotec Cytokine Secretion assay (Bisley, UK); 10 ml per 10 6 cells; diluted in cold RPMI) were added to each well. Cells were incubated at 4 1C for 15 min before addition of 1 ml warm media and incubation at 37 1C/ 5% CO 2 for 1 h to allow cytokine release from cells. Cells were then washed in FACS staining buffer and stained with detection reagents (Miltenyi Biotec Cytokine Secretion assay; 10 ml per 10 6 cells; diluted in cold FACS staining buffer) for IFN-g-phycoerythrin, IL-4-phycoerythrin, IL-10-allophycocyanin, and IL-17-allophycocyanin. aTCRb-QR and aCD4-PacBlue or aCD8-PacBlue antibodies were also added at pre-optimized concentrations to identify CD4 or CD8 T cells. Cells were then washed in FACS staining buffer before analysis. At least 100 Â 10 3 cells from each sample were collected on a Dako Cyan flow cytometer. Analysis was performed using Winlist6.0 (Verity).
Spleen cells were harvested and processed as lung cells. Cells were counted using trypan blue exclusion assay, set up in 48-well plates (2 Â 10 6 per well), and stimulated with media, specific G peptide (G184-198; 10mg ml À 1 ), or aCD3/aCD28-coated beads (Invitrogen; pre-titrated to 10 ml stock per 10 6 cells) at 37 1C/5% CO 2 for 72 h. Supernatants were harvested and stored at À 80 1C before analysis of cytokine levels by ELISA.
In vitro cytokine production from sorted DCs and CD4 T cells. Lung cells from control or IL-21-depleted mice were harvested and processed as described above. CD4 T cells from both the groups were MACS-sorted using a positive isolation kit (Miltenyi Biotech, Bisley, UK). DCs were FACS-sorted from the remaining cells by staining using aCD11c-FITC and aCD11b-phycoerythrin antibodies and collected positively stained cells on a FACS Diva sorter. DC purity of 493% was obtained. Collected DCs were washed, counted, set up at 4 Â 10 4 per well, and pulsed with a non-specific RSV G-negative control peptide (p11: G64-78) or antigen-specific peptide (p31: G184-198; 10 mg ml À 1 ). Sorted CD4 T cells (4 Â 10 5 cells per well) were added and cultured in 200 ml R10F medium in 96-well, round-bottomed plates. After 72 h, the supernatants were harvested and stored at À 80 1C for cytokine analysis later. IFN-g, IL-4, IL-10, IL-17, and IL-21 were quantified as described below.
Cytokine ELISA. Cytokine levels were quantified using paired antibodies from R&D Systems (Abingdon, UK; following the manufacturer's instructions) unless otherwise stated. In brief, microtiter plates were coated with 100 ml (1:200 dilution) of capture antibody overnight at 4 1C. After three washes with PBS containing 0.5% Tween-20, plates were blocked with 200 ml of PBS-1% bovine serum albumin and left for 2 h at room temperature. Samples and standards (diluted in PBS with 1% bovine serum albumin and 0.05% Tween 20) were incubated overnight at 4 1C. After four washes, bound cytokine was detected using biotinylated antibodies, then avidin-horseradish peroxidase, followed by O-phenylenediamine dihydrochloride (OPD), read at 490 nm. Standard curves were used to calculate sample concentrations.
RSV-specific antibody ELISA. RSV-specific IgA, IgE, IgG1, and IgG2a was detected by coating 96-well plates with RSV antigen or Hep2 control materials, incubating overnight at 4 1C with different serum dilutions (1:2 dilutions starting at 1:100), and detecting Ig with biotinconjugated anti-mouse Ig antibodies (Becton Dickinson, Oxford, UK), avidin-horseradish peroxidase, and OPD as described above. Results were expressed as optical density values.
MACS sorting and adoptive transfer of splenic CD4 T cells. Mice were immunized, challenged, and depleted of IL-21 (or not) as described above. The mice were left for 28 d, and the spleens were harvested. CD4 T cells were purified using a positive isolation kit (Miltenyi Biotech; according to the manufacturer's instructions). CD4 T-cell purity of 490% was obtained. 5 Â 10 6 cells were transferred IP into each recipient mouse 24 h before RSV challenge. Mice were monitored daily and BAL and lungs harvested 7 d PC.
Data analysis. A Student's t-test was used to analyze differences between the two groups. One-way analysis of variance (ANOVA) was used to analyze differences between more than two groups and significance was assumed at Po0.05. A Tukey's post test was used to identify differences between specific groups, with a significance threshold of Po0.05.
